全球一体化的临床阶段生物技术公司，专注代谢性疾病、消化系统疾病等领域的重大未满足临床需求，立足源头创新，以患者的综合临床获益和整体健康改善为目标，开发“First-in-Class”多靶点原创新药。
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.01.2023 | Series C | $107M | - |
Mentions in press and media 6
| Date | Title | Description |
| 14.07.2026 | Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets with Global Strategic Opportunities | SAN DIEGO, July 14, 2026 /PRNewswire/ -- Ahead of the BIO International Convention, BIOSeedin Summer Innovation Partnering Summit was successfully held at Wyndham San Diego Bayside, California. Hosted by bioSeedin, the summit's discussion t... |
| 09.07.2026 | On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations | SAN DIEGO, July 9, 2026 /PRNewswire/ -- On the eve of the highly anticipated BIO International Convention 2026, the BIOSeedin Summer Innovation Partnering Summit successfully took place in San Diego. Hosted by bioSeedin and proudly supporte... |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital flowing into the industry.
While biotech VC investments in 2022 failed to live up to 2021's banner year, the second half still saw a steady st... |
| 06.01.2023 | HighTide Therapeutics Raises $107M in Series C/C+ Financing | HighTide Therapeutics, a Rockville, MD-based biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, raised $107M in Series C/C+ funding.
The round was led by TCM Healthcare Fund, with part... |
| 05.01.2023 | Biotech firm HighTide raises $107m in Series C, C+ rounds from China investors | Global clinical-stage biotech firm HighTide Therapeutics has completed its Series C, C+ rounds of financing at $107 million from investors in China, per its announcement on Thursday.
The new rounds were led by a 30-billion-yuan ($4.4 billio... |
| - | HighTide Therapeutics | “HighTide” |
Reviews 0
